Go Pro
→ SPCX Warning - and Worst News for Stocks in 50 Years (From TradeSmith) (Ad)tc pixel Free OSUR Stock Alerts

OraSure Technologies (OSUR) Financials

OraSure Technologies logo
$4.35 0.00 (0.00%)
Closing price 07/2/2026 04:00 PM Eastern
Extended Trading
$4.35 0.00 (0.00%)
As of 07/2/2026 04:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for OraSure Technologies

Annual Income Statements for OraSure Technologies

This table shows OraSure Technologies' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 8.17 20 31 20 17 -15 -23 -17 54 -20 -69
Consolidated Net Income / (Loss)		 8.17 20 31 20 17 -15 -23 -17 54 -20 -69
Net Income / (Loss) Continuing Operations		 8.17 20 31 20 17 -15 -23 -17 54 -20 -69
Total Pre-Tax Income 		8.83 20 41 32 21 -3.52 -9.29 -16 56 -16 -65
Total Operating Income		 8.06 20 40 28 19 -5.18 -10 -22 33 -28 -72
Total Gross Profit		 80 88 99 114 95 102 118 148 172 79 48
Total Revenue		 120 128 167 182 155 172 234 387 405 186 115
Operating Revenue		 104 128 167 182 155 172 234 387 405 186 115
Total Cost of Revenue		 39 40 68 68 60 70 116 239 234 106 67
Operating Cost of Revenue		 39 40 68 68 60 70 116 239 234 106 67
Total Operating Expenses		 72 68 59 85 76 107 128 171 139 108 120
Selling, General & Admin Expense		 25 28 29 38 35 43 50 68 58 46 48
Marketing Expense		 35 30 29 31 32 34 45 49 36 31 26
Research & Development Expense		 12 9.75 13 16 20 31 34 36 34 26 43
Impairment Charge		 - - - - - 0.00 0.00 17 11 4.39 0.00
Other Special Charges / (Income)		 - - -13 0.00 -0.66 -1.10 -1.49 -0.19 -0.10 0.00 3.85
Total Other Income / (Expense), net		 0.77 0.06 0.79 3.29 2.72 1.65 0.87 6.48 24 12 7.38
Other Income / (Expense), net		 0.77 0.06 0.79 3.29 2.72 1.65 0.87 6.48 24 12 7.38
Income Tax Expense		 0.67 0.60 10 11 4.68 11 14 1.46 2.60 1.80 1.80
Other Gains / (Losses), net		 - - - - - - - 0.00 0.00 -1.70 -2.34
Basic Earnings per Share		 $0.14 $0.35 $0.52 $0.33 $0.27 $0.22 ($0.32) ($0.24) $0.73 ($0.26) ($0.94)
Weighted Average Basic Shares Outstanding		 56.40M 55.62M 59.05M 61.11M 61.68M 67.51M 71.98M 72.51M 73.35M 74.43M 73.49M
Diluted Earnings per Share		 $0.14 $0.35 $0.51 $0.33 $0.27 $0.22 ($0.32) ($0.24) $0.72 ($0.26) ($0.94)
Weighted Average Diluted Shares Outstanding		 56.85M 56.51M 61.02M 62.53M 62.17M 67.51M 71.98M 72.51M 74.39M 74.43M 73.49M
Weighted Average Basic & Diluted Shares Outstanding		 58.30M 56.30M 59.50M 61.66M 62.00M 71.95M 72.30M 73.24M 73.80M 74.80M 69.13M

Quarterly Income Statements for OraSure Technologies

This table shows OraSure Technologies' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 11 20 -3.58 -0.62 -4.51 -11 -16 -20 -14 -19 -22
Consolidated Net Income / (Loss)		 11 20 -3.58 -0.62 -4.51 -11 -16 -20 -14 -19 -22
Net Income / (Loss) Continuing Operations		 11 20 -3.58 -0.62 -4.51 -11 -16 -20 -14 -19 -22
Total Pre-Tax Income 		14 21 -3.60 0.33 -3.22 -9.51 -16 -17 -13 -18 -22
Total Operating Income		 11 3.90 -7.09 -2.74 -6.00 -12 -18 -18 -16 -20 -23
Total Gross Profit		 44 35 24 25 17 14 12 13 12 11 12
Total Revenue		 89 76 54 54 40 37 30 31 27 27 28
Operating Revenue		 89 76 54 54 40 37 30 31 27 27 28
Total Cost of Revenue		 45 41 30 30 23 24 18 18 15 16 16
Operating Cost of Revenue		 45 41 30 30 23 24 18 18 15 16 16
Total Operating Expenses		 33 31 31 27 23 26 30 31 28 31 35
Selling, General & Admin Expense		 10 14 12 12 9.83 13 14 13 11 9.82 15
Marketing Expense		 8.74 6.91 8.45 7.93 7.62 6.99 6.86 6.38 6.30 6.58 6.77
Research & Development Expense		 8.52 6.99 7.74 6.60 5.62 6.09 9.60 11 10 11 14
Other Special Charges / (Income)		 -0.04 - 0.00 0.00 0.00 - -0.52 0.73 0.38 3.25 0.09
Total Other Income / (Expense), net		 2.61 17 3.49 3.07 2.78 2.91 1.78 1.14 2.80 1.67 1.55
Other Income / (Expense), net		 2.61 17 3.49 3.07 2.78 2.91 1.78 1.14 2.80 1.67 1.55
Income Tax Expense		 2.35 0.65 -0.02 0.38 0.68 0.74 -0.46 2.00 0.05 0.21 -0.43
Other Gains / (Losses), net		 - - 0.00 -0.56 -0.61 - -0.52 -0.80 -0.37 -0.64 -1.09
Basic Earnings per Share		 $0.15 $0.28 ($0.05) ($0.01) ($0.06) ($0.14) ($0.21) ($0.26) ($0.19) ($0.28) ($0.32)
Weighted Average Basic Shares Outstanding		 73.45M 73.35M 73.95M 74.16M 74.58M 74.43M 74.87M 74.54M 73.00M 73.49M 69.68M
Diluted Earnings per Share		 $0.15 $0.27 ($0.05) ($0.01) ($0.06) ($0.14) ($0.21) ($0.26) ($0.19) ($0.28) ($0.32)
Weighted Average Diluted Shares Outstanding		 74.35M 74.39M 73.95M 74.16M 74.58M 74.43M 74.87M 74.54M 73.00M 73.49M 69.68M
Weighted Average Basic & Diluted Shares Outstanding		 73.48M 73.80M 73.96M 74.57M 74.59M 74.80M 74.80M 73.14M 71.73M 69.13M 68.85M

Annual Cash Flow Statements for OraSure Technologies

This table details how cash moves in and out of OraSure Technologies' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 1.23 15 -38 16 -13 85 -44 -33 206 -23 -68
Net Cash From Operating Activities		 16 25 28 39 9.80 5.81 -35 -47 142 27 -49
Net Cash From Continuing Operating Activities		 16 25 28 39 9.80 5.81 -35 -47 142 27 -49
Net Income / (Loss) Continuing Operations		 8.17 20 31 20 17 -15 -23 -17 54 -20 -69
Consolidated Net Income / (Loss)		 8.17 20 31 20 17 -15 -23 -17 54 -20 -69
Depreciation Expense		 5.81 5.69 6.08 6.45 7.34 9.39 12 15 21 11 10
Amortization Expense		 - -0.05 0.33 0.77 0.39 0.33 0.84 0.23 0.00 -0.56 -0.22
Non-Cash Adjustments To Reconcile Net Income		 6.49 6.16 7.09 15 -3.56 8.55 7.28 28 21 18 12
Changes in Operating Assets and Liabilities, net		 -4.69 -6.92 -16 -3.31 -11 2.47 -32 -74 46 18 -2.34
Net Cash From Investing Activities		 -6.71 -8.07 -96 -17 -20 -14 -5.50 21 66 -39 -6.81
Net Cash From Continuing Investing Activities		 -6.71 -8.07 -96 -17 -20 -14 -5.50 21 66 -39 -6.81
Purchase of Property, Plant & Equipment		 -3.74 -4.35 -4.34 -6.34 -9.31 -27 -22 -6.77 -5.80 -3.80 -4.20
Acquisitions		 - - - 0.00 -24 -3.04 - 0.00 0.00 -35 -3.61
Purchase of Investments		 -27 -34 -161 -164 -92 -90 -26 -23 -75 -53 0.00
Sale of Property, Plant & Equipment		 - - - - - 0.00 0.00 0.12 0.00 0.00 1.00
Sale and/or Maturity of Investments		 24 30 69 153 93 108 68 47 102 53 0.00
Other Investing Activities, net		 - - - 0.00 0.00 -1.90 -26 3.20 44 0.00 0.00
Net Cash From Financing Activities		 -5.69 -1.16 30 -1.89 -4.68 92 -2.82 -3.83 -3.02 -4.18 -17
Net Cash From Continuing Financing Activities		 -5.69 -1.16 30 -1.89 -4.68 92 -2.82 -3.83 -3.02 -4.18 -17
Repurchase of Common Equity		 -6.09 -3.44 -1.24 -3.59 -3.71 -2.09 -2.11 -2.25 0.00 0.00 -15
Other Financing Activities, net		 0.40 2.66 32 1.70 -0.25 -0.47 -0.70 -1.57 -3.02 -4.18 -1.90
Effect of Exchange Rate Changes		 -2.16 - - -4.20 1.95 0.83 -0.34 -2.84 1.71 -6.82 4.29

Quarterly Cash Flow Statements for OraSure Technologies

This table details how cash moves in and out of OraSure Technologies' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 32 73 -43 11 20 -11 -20 -13 -18 -17 -22
Net Cash From Operating Activities		 37 41 6.74 7.84 13 0.11 -20 -10 -10 -9.00 -14
Net Cash From Continuing Operating Activities		 37 41 6.74 7.84 13 0.11 -20 -10 -10 -9.00 -14
Net Income / (Loss) Continuing Operations		 11 20 -3.58 -0.62 -4.51 -11 -16 -20 -14 -19 -22
Consolidated Net Income / (Loss)		 11 20 -3.58 -0.62 -4.51 -11 -16 -20 -14 -19 -22
Depreciation Expense		 3.36 3.56 2.73 2.61 3.05 2.49 2.81 2.53 2.46 2.40 2.34
Amortization Expense		 0.00 - 0.01 -0.09 -0.48 0.01 -0.04 -0.11 -0.07 -0.00 -0.08
Non-Cash Adjustments To Reconcile Net Income		 9.02 6.24 6.11 5.25 3.65 3.40 2.38 4.20 2.94 2.56 3.77
Changes in Operating Assets and Liabilities, net		 13 11 1.48 0.70 11 5.01 -8.84 2.86 -1.68 5.33 2.45
Net Cash From Investing Activities		 -2.57 31 -47 5.66 7.33 -5.49 0.37 -1.94 -0.82 -4.42 -0.91
Net Cash From Continuing Investing Activities		 -2.57 31 -47 5.66 7.33 -5.49 0.37 -1.94 -0.82 -4.42 -0.91
Purchase of Property, Plant & Equipment		 -1.62 -1.29 -1.58 -1.62 -0.15 -0.46 -0.42 -1.94 -0.92 -0.92 -0.91
Sale of Property, Plant & Equipment		 - - 0.00 - - - 0.79 - 0.10 0.11 0.00
Net Cash From Financing Activities		 -0.71 -0.36 -1.30 -2.04 -0.73 -0.11 -0.95 -5.80 -5.08 -5.11 -6.28
Net Cash From Continuing Financing Activities		 -0.71 -0.36 -1.30 -2.04 -0.73 -0.11 -0.95 -5.80 -5.08 -5.11 -6.28
Repurchase of Common Equity		 -0.20 1.86 -1.46 1.46 - -0.02 0.00 -4.06 -5.00 -5.04 -5.00
Other Financing Activities, net		 -0.51 -2.22 0.16 -3.50 -0.73 -0.10 -0.95 -1.74 -0.08 -0.08 -1.28
Effect of Exchange Rate Changes		 -2.07 1.31 -2.18 -0.37 1.04 -5.31 0.12 4.97 -2.13 1.33 -1.22
Cash Income Taxes Paid		 -6.36 - 0.59 1.02 0.03 - 1.80 0.78 0.00 - -0.08

Annual Balance Sheets for OraSure Technologies

This table presents OraSure Technologies' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 189 208 296 316 349 454 461 444 483 480 403
Total Current Assets		 137 156 222 219 225 289 299 325 386 333 262
Cash & Equivalents		 94 108 71 88 76 161 117 84 290 268 199
Accounts Receivable		 19 20 43 35 37 39 45 71 40 24 22
Inventories, net		 13 12 19 23 23 32 53 96 48 34 31
Prepaid Expenses		 1.53 1.72 1.66 1.93 2.43 3.86 7.94 6.27 6.04 3.96 5.22
Current Deferred & Refundable Income Taxes		 - - - - - - - - - - 0.00
Other Current Assets		 1.36 2.14 2.49 3.09 5.68 4.93 40 42 2.23 3.49 4.15
Plant, Property, & Equipment, net		 20 20 21 24 30 52 73 59 45 45 39
Total Noncurrent Assets		 33 31 53 72 94 114 71 58 51 101 102
Long-Term Investments		 - - 21 45 33 48 - - 0.00 28 26
Noncurrent Note & Lease Receivables		 - - - - - - 2.49 1.29 0.58 0.15 0.15
Goodwill		 18 19 20 19 36 40 40 35 36 40 43
Intangible Assets		 13 10 8.22 5.14 15 18 14 12 1.21 17 19
Noncurrent Deferred & Refundable Income Taxes		 - - - - - - - - 0.00 0.16 0.27
Other Noncurrent Operating Assets		 1.68 2.33 3.93 3.55 10 7.75 14 10 13 15 13
Total Liabilities & Shareholders' Equity		 189 208 296 316 349 454 461 444 483 480 403
Total Liabilities		 30 22 38 32 42 56 80 80 52 69 62
Total Current Liabilities		 25 17 32 28 33 46 68 69 40 33 40
Short-Term Debt		 - - - - 3.50 0.40 0.21 0.07 - 0.00 18
Accounts Payable		 5.09 4.63 10 11 9.57 17 28 38 13 8.17 6.52
Accrued Expenses		 10 11 21 14 14 22 34 26 23 20 11
Current Deferred Revenue		 9.74 1.39 1.31 3.52 3.71 4.81 2.94 - - 2.96 1.52
Other Current Liabilities		 - - - - 1.65 1.64 3.12 5.22 3.68 2.17 2.23
Total Noncurrent Liabilities		 4.65 4.75 5.88 4.21 9.44 9.41 12 11 13 36 23
Other Noncurrent Operating Liabilities		 1.77 2.30 3.93 3.31 8.54 8.22 10 10 12 36 23
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 159 186 258 283 307 399 381 364 431 410 341
Total Preferred & Common Equity		 159 186 258 283 307 399 381 364 431 410 341
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 159 186 258 283 307 399 381 364 431 410 341
Common Stock		 345 351 388 401 402 505 511 520 530 538 531
Retained Earnings		 -170 -150 -120 -99 -83 -97 -120 -138 -84 -103 -172
Accumulated Other Comprehensive Income / (Loss)		 -16 -14 -10 -19 -12 -9.10 -10 -18 -15 -24 -18

Quarterly Balance Sheets for OraSure Technologies

This table presents OraSure Technologies' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 458 468 466 464 458 445 423 379
Total Current Assets		 356 349 351 350 314 301 283 241
Cash & Equivalents		 218 247 258 279 248 235 216 177
Accounts Receivable		 53 34 38 27 22 26 24 25
Inventories, net		 59 43 38 39 36 33 33 30
Prepaid Expenses		 6.42 4.69 3.55 3.04 5.89 3.34 4.71 5.23
Current Deferred & Refundable Income Taxes		 - - - - - - - 1.61
Other Current Assets		 12 2.83 3.78 2.72 3.13 4.25 4.12 1.87
Plant, Property, & Equipment, net		 48 43 40 38 43 42 41 38
Total Noncurrent Assets		 54 75 75 76 101 101 99 101
Long-Term Investments		 - 28 28 29 28 27 27 25
Noncurrent Note & Lease Receivables		 0.79 0.16 0.17 0.16 0.13 0.18 0.16 0.20
Goodwill		 35 35 35 35 40 42 41 43
Intangible Assets		 3.79 1.01 0.83 0.67 17 17 17 19
Noncurrent Deferred & Refundable Income Taxes		 0.05 - - - 0.54 0.00 0.21 0.64
Other Noncurrent Operating Assets		 14 11 11 11 14 15 14 13
Total Liabilities & Shareholders' Equity		 458 468 466 464 458 445 423 379
Total Liabilities		 54 41 41 39 61 64 61 66
Total Current Liabilities		 41 29 29 28 25 42 40 44
Short-Term Debt		 0.00 - - - - 17 17 19
Accounts Payable		 15 13 9.09 9.58 7.82 6.38 6.36 11
Accrued Expenses		 21 13 16 15 13 14 13 12
Current Deferred Revenue		 1.82 1.60 1.45 1.62 2.51 2.45 1.88 0.87
Other Current Liabilities		 3.02 2.11 2.12 1.57 2.13 2.15 2.11 2.22
Total Noncurrent Liabilities		 13 12 12 11 36 22 21 22
Other Noncurrent Operating Liabilities		 13 12 11 10 36 22 21 22
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 405 426 426 426 396 381 362 313
Total Preferred & Common Equity		 405 426 426 426 396 381 362 313
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 405 426 426 426 396 381 362 313
Common Stock		 526 531 533 535 540 537 535 528
Retained Earnings		 -104 -88 -88 -93 -119 -139 -153 -195
Accumulated Other Comprehensive Income / (Loss)		 -17 -17 -19 -17 -24 -17 -20 -20

Annual Metrics And Ratios for OraSure Technologies

This table displays calculated financial ratios and metrics derived from OraSure Technologies' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 56,482,384.00 55,730,629.00 60,648,324.00 61,249,469.00 61,726,370.00 71,732,752.00 72,038,439.00 72,622,043.00 73,484,272.00 - 71,733,530.00
DEI Adjusted Shares Outstanding		 56,482,384.00 55,730,629.00 60,648,324.00 61,249,469.00 61,726,370.00 71,732,752.00 72,038,439.00 72,622,043.00 73,484,272.00 - 71,733,530.00
DEI Earnings Per Adjusted Shares Outstanding		 0.14 0.35 0.51 0.33 0.27 -0.21 -0.32 -0.24 0.73 - -0.96
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 12.45% 7.08% 30.32% 8.79% -14.93% 11.07% 36.08% 65.82% 4.64% -54.17% -38.10%
EBITDA Growth		 618.96% 77.37% 82.70% -17.91% -25.37% -78.70% -48.26% -104.34% 55,637.41% -107.37% -859.35%
EBIT Growth		 306.79% 130.11% 101.90% -22.70% -32.74% -116.52% -163.68% -68.69% 458.90% -128.44% -303.64%
NOPAT Growth		 321.67% 163.90% 54.34% -39.76% -20.51% -124.94% -96.33% -117.99% 300.99% -163.44% -154.76%
Net Income Growth		 277.00% 141.46% 56.94% -34.10% -18.34% -189.59% -54.12% 25.50% 413.17% -136.34% -252.47%
EPS Growth		 275.00% 150.00% 45.71% -35.29% -18.18% -18.52% -245.45% 25.00% 400.00% -136.11% -261.54%
Operating Cash Flow Growth		 109.58% 55.95% 14.46% 38.83% -74.92% -40.77% -709.30% -33.41% 399.95% -80.67% -279.09%
Free Cash Flow Firm Growth		 170.46% 26.68% 6.79% 28.84% -237.12% -1.19% -208.85% 24.46% 350.04% -95.67% -1,227.72%
Invested Capital Growth		 -4.47% 11.67% 25.57% 0.69% 47.33% 17.34% 48.53% 19.87% -44.46% -18.53% 17.24%
Revenue Q/Q Growth		 3.19% 2.49% 10.98% -0.97% -0.37% 8.32% 0.31% 18.15% -10.43% -17.14% -8.50%
EBITDA Q/Q Growth		 84.85% 11.30% 7.70% 11.48% -22.10% 188.31% -83.16% 99.45% 6.80% -122.24% -19.78%
EBIT Q/Q Growth		 323.60% 15.28% 8.21% 13.87% -30.99% 46.12% -228.81% 61.04% 9.94% -212.48% -16.03%
NOPAT Q/Q Growth		 1,131.74% 17.01% 0.48% 12.14% -32.24% 42.33% 32.65% 51.99% -25.58% -88.28% -11.95%
Net Income Q/Q Growth		 808.45% 15.05% 0.39% 17.12% -32.06% -4.03% -114.03% 60.46% 8.65% -271.55% -14.10%
EPS Q/Q Growth		 600.00% 16.67% -1.92% 13.79% -30.77% 195.65% -203.23% 60.00% 7.46% -273.33% -17.50%
Operating Cash Flow Q/Q Growth		 10.71% -4.84% -5.45% 72.95% -60.97% 399.74% -86.35% -12.46% 72.23% -60.11% -22.81%
Free Cash Flow Firm Q/Q Growth		 -6.40% -3.05% -15.56% 1,831.23% -934.52% 12.54% -6.53% 34.08% 40.17% -87.89% -11.29%
Invested Capital Q/Q Growth		 12.17% 17.30% 17.69% -3.04% 17.18% 13.49% 13.44% 5.03% -22.07% -3.29% -1.59%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 67.07% 68.66% 59.23% 62.51% 61.18% 59.32% 50.33% 38.31% 42.33% 42.72% 41.90%
EBITDA Margin		 12.23% 20.25% 28.39% 21.42% 18.80% 3.60% 1.37% -0.04% 19.04% -3.06% -47.48%
Operating Margin		 6.73% 15.81% 24.09% 15.64% 12.04% -3.01% -4.35% -5.72% 8.06% -15.20% -62.57%
EBIT Margin		 7.38% 15.85% 24.56% 17.45% 13.80% -2.05% -3.98% -4.05% 13.87% -8.61% -56.15%
Profit (Net Income) Margin		 6.82% 15.38% 18.52% 11.22% 10.77% -8.69% -9.84% -4.42% 13.23% -10.49% -59.76%
Tax Burden Percent		 92.47% 97.03% 75.42% 64.31% 78.08% 423.44% 247.50% 109.30% 95.37% 121.87% 106.42%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 7.53% 2.97% 24.58% 35.69% 21.92% 0.00% 0.00% 0.00% 4.63% 0.00% 0.00%
Return on Invested Capital (ROIC)		 12.53% 31.97% 41.46% 22.36% 14.32% -2.76% -4.04% -6.70% 15.87% -15.54% -40.59%
ROIC Less NNEP Spread (ROIC-NNEP)		 11.81% 31.92% 41.06% 21.24% 13.23% 2.34% 3.41% -5.54% 4.69% -15.63% -33.29%
Return on Net Nonoperating Assets (RNNOA)		 -7.39% -20.55% -27.52% -14.82% -8.68% -1.47% -1.87% 2.10% -2.37% 10.90% 22.29%
Return on Equity (ROE)		 5.13% 11.42% 13.94% 7.53% 5.64% -4.23% -5.90% -4.60% 13.50% -4.64% -18.30%
Cash Return on Invested Capital (CROIC)		 17.10% 20.94% 18.79% 21.67% -23.95% -18.72% -43.09% -24.77% 73.04% 4.88% -56.46%
Operating Return on Assets (OROA)		 4.66% 10.23% 16.28% 10.37% 6.42% -0.88% -2.03% -3.46% 12.14% -3.32% -14.63%
Return on Assets (ROA)		 4.31% 9.93% 12.28% 6.67% 5.01% -3.71% -5.02% -3.79% 11.58% -4.05% -15.57%
Return on Common Equity (ROCE)		 5.13% 11.42% 13.94% 7.53% 5.64% -4.23% -5.90% -4.60% 13.50% -4.64% -18.30%
Return on Equity Simple (ROE_SIMPLE)		 5.12% 10.61% 11.99% 7.20% 5.42% -3.74% -6.04% -4.70% 0.00% -4.75% 0.00%
Net Operating Profit after Tax (NOPAT)		 7.45 20 30 18 15 -3.62 -7.11 -16 31 -20 -50
NOPAT Margin		 6.22% 15.34% 18.17% 10.06% 9.40% -2.11% -3.04% -4.00% 7.69% -10.64% -43.80%
Net Nonoperating Expense Percent (NNEP)		 0.72% 0.05% 0.40% 1.12% 1.10% -5.10% -7.45% -1.15% 11.18% 0.09% -7.30%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - -4.26% 7.24% -4.82% -14.02%
Cost of Revenue to Revenue		 32.93% 31.34% 40.77% 37.49% 38.82% 40.68% 49.67% 61.69% 57.67% 57.28% 58.10%
SG&A Expenses to Revenue		 21.29% 22.12% 17.55% 21.09% 22.82% 24.84% 21.54% 17.60% 14.35% 24.87% 41.45%
R&D to Revenue		 9.73% 7.61% 8.00% 8.94% 12.70% 18.07% 14.62% 9.35% 8.32% 14.02% 36.97%
Operating Expenses to Revenue		 60.34% 52.86% 35.15% 46.87% 49.14% 62.34% 54.68% 44.03% 34.27% 57.92% 104.47%
Earnings before Interest and Taxes (EBIT)		 8.83 20 41 32 21 -3.52 -9.29 -16 56 -16 -65
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 15 26 47 39 29 6.19 3.20 -0.14 77 -5.69 -55
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 2.28 2.63 4.43 2.52 1.61 1.91 1.65 0.96 1.40 0.66 0.51
Price to Tangible Book Value (P/TBV)		 2.83 3.12 4.98 2.75 1.93 2.23 1.92 1.10 1.53 0.76 0.62
Price to Revenue (P/Rev)		 3.04 3.82 6.85 3.94 3.21 4.42 2.68 0.90 1.49 1.45 1.51
Price to Earnings (P/E)		 44.54 24.81 36.96 35.08 29.76 0.00 0.00 0.00 11.23 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 2.25% 4.03% 2.71% 2.85% 3.36% 0.00% 0.00% 0.00% 8.90% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 4.52 5.68 11.87 6.27 2.56 3.54 2.25 0.95 2.23 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 2.19 2.87 5.79 2.83 2.00 2.93 2.03 0.62 0.77 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 17.93 14.19 20.39 13.20 10.65 81.19 147.73 0.00 4.04 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 29.71 18.13 23.57 16.21 14.50 0.00 0.00 0.00 5.55 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 35.22 18.73 31.87 28.12 21.29 0.00 0.00 0.00 10.01 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 16.64 14.98 34.35 13.15 31.56 86.55 0.00 0.00 2.20 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 25.81 28.60 70.32 29.01 0.00 0.00 0.00 0.00 2.18 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.05
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.63 -0.64 -0.67 -0.70 -0.66 -0.63 -0.55 -0.38 -0.51 -0.70 -0.67
Leverage Ratio		 1.19 1.15 1.14 1.13 1.13 1.14 1.18 1.22 1.17 1.14 1.18
Compound Leverage Factor		 1.19 1.15 1.14 1.13 1.13 1.14 1.18 1.22 1.17 1.14 1.18
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 1.13% 0.10% 0.05% 0.02% 0.00% 0.00% 5.12%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 1.13% 0.10% 0.05% 0.02% 0.00% 0.00% 5.12%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 98.87% 99.90% 99.95% 99.98% 100.00% 100.00% 94.88%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.12 0.06 0.06 -0.47 0.00 0.00 -0.34
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 -6.41 -41.47 -47.72 796.99 0.00 0.00 3.79
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.24 -0.11 -0.03 0.00 0.00 0.00 -0.36
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 -12.82 70.84 21.48 7.14 0.00 0.00 4.11
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 7.54 14.02 19.23 14.53 8.03 8.84 5.35 3.65 8.77 3.06 1.49
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 5.42 9.02 6.88 7.84 6.86 6.21 4.40 4.71 9.77 9.95 6.58
Quick Ratio		 4.78 8.02 6.10 6.84 5.91 5.34 2.91 2.63 8.36 8.71 5.57
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 10 13 14 18 -24 -25 -76 -57 143 6.21 -70
Operating Cash Flow to CapEx		 421.29% 565.08% 649.20% 616.17% 105.26% 21.77% -161.61% -709.48% 2,440.24% 720.94% -1,533.41%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.63 0.65 0.66 0.59 0.47 0.43 0.51 0.86 0.87 0.39 0.26
Accounts Receivable Turnover		 6.76 6.56 5.36 4.70 4.31 4.53 5.55 6.67 7.31 5.81 5.00
Inventory Turnover		 2.72 3.21 4.37 3.23 2.61 2.54 2.73 3.21 3.26 2.60 2.05
Fixed Asset Turnover		 6.30 6.39 8.07 7.96 5.66 4.18 3.73 5.83 7.74 4.11 2.73
Accounts Payable Turnover		 6.44 8.27 9.17 6.54 5.95 5.18 5.11 7.24 9.14 9.98 9.10
Days Sales Outstanding (DSO)		 53.97 55.65 68.11 77.69 84.74 80.54 65.73 54.69 49.95 62.84 73.02
Days Inventory Outstanding (DIO)		 134.26 113.76 83.45 113.12 140.00 143.74 133.64 113.64 111.86 140.28 178.22
Days Payable Outstanding (DPO)		 56.63 44.16 39.82 55.79 61.31 70.47 71.43 50.42 39.94 36.56 40.13
Cash Conversion Cycle (CCC)		 131.60 125.26 111.73 135.02 163.43 153.81 127.94 117.91 121.87 166.55 211.11
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 58 65 81 82 121 142 211 253 140 114 134
Invested Capital Turnover		 2.01 2.08 2.28 2.22 1.52 1.31 1.33 1.67 2.06 1.46 0.93
Increase / (Decrease) in Invested Capital		 -2.72 6.78 17 0.56 39 21 69 42 -112 -26 20
Enterprise Value (EV)		 262 368 967 514 309 503 473 239 312 -27 -33
Market Capitalization		 364 489 1,144 715 496 759 626 350 603 269 174
Book Value per Share		 $2.82 $3.33 $4.26 $4.63 $4.98 $5.56 $5.28 $5.02 $5.86 $5.50 $4.75
Tangible Book Value per Share		 $2.28 $2.81 $3.79 $4.24 $4.15 $4.74 $4.52 $4.37 $5.36 $4.73 $3.88
Total Capital		 159 186 258 283 311 399 381 364 431 410 359
Total Debt		 0.00 0.00 0.00 0.00 3.50 0.40 0.21 0.07 0.00 0.00 18
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -101 -121 -177 -201 -186 -257 -153 -111 -290 -296 -207
Capital Expenditures (CapEx)		 3.74 4.35 4.34 6.34 9.31 27 22 6.65 5.80 3.80 3.20
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 10 18 34 35 39 33 78 145 57 32 41
Debt-free Net Working Capital (DFNWC)		 111 139 190 191 195 243 231 256 347 300 240
Net Working Capital (NWC)		 111 139 190 191 192 242 231 256 347 300 222
Net Nonoperating Expense (NNE)		 -0.72 -0.06 -0.60 -2.11 -2.12 11 16 1.62 -22 -0.28 18
Net Nonoperating Obligations (NNO)		 -101 -121 -177 -201 -186 -257 -170 -112 -290 -296 -207
Total Depreciation and Amortization (D&A)		 5.81 5.64 6.40 7.22 7.73 9.71 12 16 21 10 9.97
Debt-free, Cash-free Net Working Capital to Revenue		 8.49% 14.16% 20.21% 19.13% 25.22% 19.45% 33.55% 37.51% 13.94% 17.21% 35.83%
Debt-free Net Working Capital to Revenue		 93.12% 108.51% 113.53% 105.28% 126.35% 141.40% 99.05% 66.12% 85.56% 161.30% 209.09%
Net Working Capital to Revenue		 93.12% 108.51% 113.53% 105.28% 124.08% 141.16% 98.96% 66.10% 85.56% 161.30% 193.11%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.14 $0.35 $0.52 $0.33 $0.27 ($0.22) ($0.32) ($0.25) $0.73 ($0.26) ($0.94)
Adjusted Weighted Average Basic Shares Outstanding		 56.40M 55.62M 59.05M 61.11M 61.68M 67.51M 71.98M 72.51M 73.35M 74.43M 73.49M
Adjusted Diluted Earnings per Share		 $0.14 $0.35 $0.51 $0.33 $0.27 ($0.22) ($0.32) ($0.25) $0.72 ($0.26) ($0.94)
Adjusted Weighted Average Diluted Shares Outstanding		 56.85M 56.51M 61.02M 62.53M 62.17M 67.51M 71.98M 72.51M 74.39M 74.43M 73.49M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 55.48M 57.66M 60.97M 61.66M 62.00M 71.95M 72.30M 73.24M 73.80M 74.80M 69.13M
Normalized Net Operating Profit after Tax (NOPAT)		 7.45 20 21 18 14 -4.39 -8.15 -3.67 41 -17 -48
Normalized NOPAT Margin		 6.22% 15.34% 12.52% 10.06% 9.06% -2.56% -3.49% -0.95% 10.21% -8.99% -41.46%
Pre Tax Income Margin		 7.38% 15.85% 24.56% 17.45% 13.80% -2.05% -3.98% -4.05% 13.87% -8.61% -56.15%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 74.57% 17.46% 4.01% 17.61% 22.29% -13.99% -9.19% -13.16% 0.00% -18.19% -21.88%

Quarterly Metrics And Ratios for OraSure Technologies

This table displays calculated financial ratios and metrics derived from OraSure Technologies' official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 73,414,695.00 73,484,272.00 73,796,268.00 73,959,289.00 74,568,307.00 - 74,800,131.00 74,800,131.00 73,136,987.00 71,733,530.00 69,126,173.00
DEI Adjusted Shares Outstanding		 73,414,695.00 73,484,272.00 73,796,268.00 73,959,289.00 74,568,307.00 - 74,800,131.00 74,800,131.00 73,136,987.00 71,733,530.00 69,126,173.00
DEI Earnings Per Adjusted Shares Outstanding		 0.15 0.27 -0.05 -0.01 -0.06 - -0.21 -0.26 -0.19 -0.27 -0.32
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -23.42% -38.35% -65.07% -36.41% -55.25% -50.65% -44.71% -42.50% -32.14% -28.53% -6.70%
EBITDA Growth		 99.00% 25.38% -102.84% -46.99% -103.85% -128.87% -1,415.61% -610.04% -1,578.46% -128.67% -47.43%
EBIT Growth		 203.37% 32.52% -113.34% 106.57% -123.83% -145.88% -343.42% -5,281.29% -313.02% -93.88% -35.99%
NOPAT Growth		 727.03% -74.44% -120.25% 110.27% -146.65% -330.19% -150.25% -2,829.62% -168.21% -61.89% -31.09%
Net Income Growth		 99.45% 27.04% -113.17% 87.18% -140.39% -153.77% -347.54% -3,102.11% -204.24% -78.67% -39.51%
EPS Growth		 87.50% 22.73% -113.51% 85.71% -140.00% -151.85% -320.00% -2,500.00% -216.67% -100.00% -52.38%
Operating Cash Flow Growth		 126.68% 329.66% 12.28% -86.30% -65.68% -99.74% -392.82% -230.33% -179.41% -8,353.21% 29.59%
Free Cash Flow Firm Growth		 229.49% 528.44% 3,301.58% 117.54% -17.03% -85.10% -100.30% -123.18% -150.72% -295.24% -5,872.10%
Invested Capital Growth		 -25.14% -44.46% -52.84% -37.24% -34.35% -18.53% -9.02% 4.18% 15.21% 17.24% 7.72%
Revenue Q/Q Growth		 4.38% -14.92% -28.66% 0.38% -26.54% -6.19% -20.07% 4.38% -13.31% -1.19% 4.34%
EBITDA Q/Q Growth		 215.07% 43.96% -103.59% 425.83% -122.90% -978.46% -88.32% -9.65% 24.63% -46.93% -21.41%
EBIT Q/Q Growth		 372.19% 53.41% -117.38% 109.05% -1,087.12% -195.43% -68.00% -5.75% 21.31% -38.68% -17.84%
NOPAT Q/Q Growth		 300.01% -58.05% -231.48% 109.31% -1,008.41% -107.00% -42.94% -1.55% 10.74% -24.94% -15.75%
Net Income Q/Q Growth		 332.67% 79.88% -117.85% 82.84% -632.85% -139.49% -48.60% -22.77% 30.37% -40.65% -16.03%
EPS Q/Q Growth		 314.29% 80.00% -118.52% 80.00% -500.00% -133.33% -50.00% -23.81% 26.92% -47.37% -14.29%
Operating Cash Flow Q/Q Growth		 -35.48% 11.96% -83.71% 16.40% 61.68% -99.14% -18,203.67% 48.19% 1.49% 10.67% -54.46%
Free Cash Flow Firm Q/Q Growth		 93.67% 67.10% 24.05% -45.81% -26.13% -69.99% -102.48% -4,114.97% -61.66% -15.52% 24.13%
Invested Capital Q/Q Growth		 -13.57% -22.07% -5.23% -1.69% -9.58% -3.29% 5.83% 12.58% -0.01% -1.59% -2.76%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 49.72% 46.29% 44.46% 45.44% 42.77% 36.23% 41.09% 42.12% 43.46% 40.98% 42.27%
EBITDA Margin		 18.91% 32.00% -1.61% 5.22% -1.63% -18.72% -44.10% -46.33% -40.28% -59.90% -69.69%
Operating Margin		 12.21% 5.14% -13.10% -5.04% -15.03% -33.16% -59.30% -57.70% -59.41% -75.11% -83.33%
EBIT Margin		 15.14% 27.31% -6.65% 0.60% -8.06% -25.39% -53.36% -54.07% -49.07% -68.87% -77.78%
Profit (Net Income) Margin		 12.51% 26.45% -6.62% -1.13% -11.29% -28.83% -53.59% -63.03% -50.63% -72.06% -80.13%
Tax Burden Percent		 82.62% 96.88% 99.50% -188.65% 140.06% 113.54% 100.43% 116.59% 103.17% 104.63% 103.02%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 17.38% 3.12% 0.00% 116.87% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 21.73% 10.27% -13.47% 1.37% -15.83% -33.90% -52.86% -41.94% -41.11% -48.72% -52.48%
ROIC Less NNEP Spread (ROIC-NNEP)		 20.41% 2.17% -14.15% 1.82% -15.71% -33.18% -51.59% -39.32% -40.19% -46.65% -49.83%
Return on Net Nonoperating Assets (RNNOA)		 -8.92% -1.10% 7.00% -1.07% 10.07% 23.14% 35.66% 26.31% 27.21% 31.23% 32.19%
Return on Equity (ROE)		 12.81% 9.18% -6.47% 0.30% -5.76% -10.76% -17.19% -15.63% -13.90% -17.49% -20.30%
Cash Return on Invested Capital (CROIC)		 48.68% 73.04% 72.36% 48.37% 34.42% 4.88% -12.01% -32.53% -49.52% -56.46% -50.61%
Operating Return on Assets (OROA)		 15.39% 23.89% -4.37% 0.36% -3.92% -9.80% -18.64% -16.44% -13.91% -17.95% -21.01%
Return on Assets (ROA)		 12.72% 23.14% -4.35% -0.67% -5.49% -11.13% -18.72% -19.16% -14.35% -18.78% -21.65%
Return on Common Equity (ROCE)		 12.81% 9.18% -6.47% 0.30% -5.76% -10.76% -17.19% -15.63% -13.90% -17.49% -20.30%
Return on Equity Simple (ROE_SIMPLE)		 12.20% 0.00% 5.36% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 9.00 3.78 -4.97 0.46 -4.20 -8.69 -12 -13 -11 -14 -16
NOPAT Margin		 10.09% 4.98% -9.17% 0.85% -10.52% -23.21% -41.51% -40.39% -41.58% -52.58% -58.33%
Net Nonoperating Expense Percent (NNEP)		 1.32% 8.10% 0.68% -0.45% -0.12% -0.72% -1.27% -2.62% -0.92% -2.07% -2.66%
Return On Investment Capital (ROIC_SIMPLE)		 - 0.88% -1.16% 0.11% -0.99% -2.12% -3.14% -3.17% -2.97% -3.92% -4.90%
Cost of Revenue to Revenue		 50.28% 53.71% 55.54% 54.56% 57.23% 63.77% 58.91% 57.88% 56.54% 59.02% 57.73%
SG&A Expenses to Revenue		 11.27% 18.46% 21.49% 21.80% 24.63% 34.46% 47.12% 40.57% 40.91% 36.69% 52.13%
R&D to Revenue		 9.55% 9.21% 14.29% 12.15% 14.09% 16.26% 32.08% 36.49% 37.31% 42.66% 48.90%
Operating Expenses to Revenue		 37.50% 41.15% 57.56% 50.48% 57.80% 69.39% 100.39% 99.82% 102.87% 116.10% 125.60%
Earnings before Interest and Taxes (EBIT)		 14 21 -3.60 0.33 -3.22 -9.51 -16 -17 -13 -18 -22
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 17 24 -0.87 2.84 -0.65 -7.01 -13 -14 -11 -16 -19
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.08 1.40 1.06 0.74 0.75 0.66 0.64 0.59 0.65 0.51 0.66
Price to Tangible Book Value (P/TBV)		 1.19 1.53 1.16 0.81 0.82 0.76 0.74 0.70 0.77 0.62 0.83
Price to Revenue (P/Rev)		 0.96 1.49 1.49 1.15 1.42 1.45 1.56 1.62 1.87 1.51 1.84
Price to Earnings (P/E)		 8.82 11.23 19.86 11.65 28.01 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 11.34% 8.90% 5.04% 8.58% 3.57% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 1.17 2.23 1.22 0.15 0.09 0.00 0.00 0.00 0.07 0.00 0.19
Enterprise Value to Revenue (EV/Rev)		 0.46 0.77 0.53 0.07 0.05 0.00 0.00 0.00 0.07 0.00 0.22
Enterprise Value to EBITDA (EV/EBITDA)		 2.91 4.04 3.54 0.46 0.43 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 4.11 5.55 6.30 0.64 0.77 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 5.02 10.01 143.02 4.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 2.56 2.20 1.14 0.21 0.16 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 2.06 2.18 1.08 0.24 0.21 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.04 0.05 0.05 0.06
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.44 -0.51 -0.49 -0.59 -0.64 -0.70 -0.69 -0.67 -0.68 -0.67 -0.65
Leverage Ratio		 1.19 1.17 1.13 1.12 1.11 1.14 1.12 1.13 1.13 1.18 1.18
Compound Leverage Factor		 1.19 1.17 1.13 1.12 1.11 1.14 1.12 1.13 1.13 1.18 1.18
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 4.27% 4.54% 5.12% 5.65%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 4.27% 4.54% 5.12% 5.65%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 95.73% 95.46% 94.88% 94.35%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.48 -0.38 -0.34 -0.31
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 6.92 4.95 3.79 3.01
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.45 -0.38 -0.36 -0.35
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 6.45 5.02 4.11 3.37
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 6.47 8.53 7.78 5.82 5.97 3.10 3.10 2.54 2.68 1.87 1.90
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 8.71 9.77 11.97 12.17 12.60 9.95 12.34 7.12 7.03 6.58 5.46
Quick Ratio		 6.80 8.36 10.23 10.59 11.00 8.71 10.58 6.15 5.98 5.57 4.58
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 69 116 144 78 58 17 -0.43 -18 -29 -34 -26
Operating Cash Flow to CapEx		 2,275.06% 3,219.14% 426.79% 485.10% 8,746.21% 23.90% 0.00% -528.05% -1,226.67% -1,110.62% -1,521.91%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.02 0.87 0.66 0.59 0.49 0.39 0.35 0.30 0.28 0.26 0.27
Accounts Receivable Turnover		 7.89 7.31 4.31 6.02 5.58 5.81 5.82 4.33 4.91 5.00 4.88
Inventory Turnover		 3.86 3.26 2.90 2.61 2.51 2.60 2.38 2.30 2.07 2.05 1.98
Fixed Asset Turnover		 6.80 7.74 6.10 6.11 5.21 4.11 3.77 3.36 3.18 2.73 2.79
Accounts Payable Turnover		 9.63 9.14 8.72 10.83 10.05 9.98 9.17 10.66 9.40 9.10 7.08
Days Sales Outstanding (DSO)		 46.25 49.95 84.76 60.61 65.39 62.84 62.73 84.31 74.41 73.02 74.80
Days Inventory Outstanding (DIO)		 94.62 111.86 125.72 140.08 145.24 140.28 153.10 158.57 176.08 178.22 184.38
Days Payable Outstanding (DPO)		 37.92 39.94 41.86 33.71 36.33 36.56 39.81 34.24 38.84 40.13 51.55
Cash Conversion Cycle (CCC)		 102.94 121.87 168.61 166.99 174.30 166.55 176.02 208.64 211.65 211.11 207.63
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 180 140 133 131 118 114 121 136 136 134 130
Invested Capital Turnover		 2.15 2.06 1.47 1.61 1.50 1.46 1.27 1.04 0.99 0.93 0.90
Increase / (Decrease) in Invested Capital		 -60 -112 -149 -78 -62 -26 -12 5.46 18 20 9.33
Enterprise Value (EV)		 210 312 162 20 11 -27 -23 -20 8.92 -33 24
Market Capitalization		 435 603 454 315 318 269 252 224 235 174 207
Book Value per Share		 $5.52 $5.86 $5.78 $5.76 $5.71 $5.50 $5.30 $5.09 $4.95 $4.75 $4.53
Tangible Book Value per Share		 $4.99 $5.36 $5.29 $5.27 $5.22 $4.73 $4.53 $4.30 $4.15 $3.88 $3.64
Total Capital		 405 431 426 426 426 410 396 398 379 359 332
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 17 17 18 19
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -225 -290 -292 -295 -307 -296 -275 -245 -226 -207 -183
Capital Expenditures (CapEx)		 1.62 1.29 1.58 1.62 0.15 0.46 -0.37 1.94 0.82 0.81 0.91
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 91 57 56 55 44 32 41 41 44 41 39
Debt-free Net Working Capital (DFNWC)		 316 347 319 322 322 300 288 276 260 240 215
Net Working Capital (NWC)		 316 347 319 322 322 300 288 259 243 222 197
Net Nonoperating Expense (NNE)		 -2.16 -16 -1.38 1.08 0.31 2.10 3.62 7.07 2.45 5.21 6.09
Net Nonoperating Obligations (NNO)		 -225 -290 -293 -295 -307 -296 -275 -245 -226 -207 -183
Total Depreciation and Amortization (D&A)		 3.36 3.56 2.73 2.51 2.57 2.50 2.77 2.42 2.38 2.40 2.26
Debt-free, Cash-free Net Working Capital to Revenue		 20.02% 13.94% 18.26% 20.04% 19.53% 17.21% 25.24% 29.95% 34.62% 35.83% 34.08%
Debt-free Net Working Capital to Revenue		 69.70% 85.56% 104.84% 117.79% 143.75% 161.30% 178.41% 199.28% 206.83% 209.09% 190.66%
Net Working Capital to Revenue		 69.70% 85.56% 104.84% 117.79% 143.75% 161.30% 178.41% 187.02% 193.12% 193.11% 174.05%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.15 $0.28 ($0.05) ($0.01) ($0.06) ($0.14) ($0.21) ($0.26) ($0.19) ($0.28) ($0.32)
Adjusted Weighted Average Basic Shares Outstanding		 73.45M 73.35M 73.95M 74.16M 74.58M 74.43M 74.87M 74.54M 73.00M 73.49M 69.68M
Adjusted Diluted Earnings per Share		 $0.15 $0.27 ($0.05) ($0.01) ($0.06) ($0.14) ($0.21) ($0.26) ($0.19) ($0.28) ($0.32)
Adjusted Weighted Average Diluted Shares Outstanding		 74.35M 74.39M 73.95M 74.16M 74.58M 74.43M 74.87M 74.54M 73.00M 73.49M 69.68M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 73.48M 73.80M 73.96M 74.57M 74.59M 74.80M 74.80M 73.14M 71.73M 69.13M 68.85M
Normalized Net Operating Profit after Tax (NOPAT)		 14 7.00 -2.63 -1.18 -4.20 -8.69 -13 -12 -11 -12 -16
Normalized NOPAT Margin		 15.78% 9.22% -4.86% -2.17% -10.52% -23.21% -42.72% -38.75% -40.61% -44.08% -58.10%
Pre Tax Income Margin		 15.14% 27.31% -6.65% 0.60% -8.06% -25.39% -53.36% -54.07% -49.07% -68.87% -77.78%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 4.27% 0.00% 9.45% 0.88% 0.33% -18.19% 4.58% -16.75% -22.49% -21.88% -26.70%

Financials Breakdown Chart

Key Financial Trends

OraSure Technologies (NASDAQ: OSUR) is showing improving top-line stability, but profitability and cash generation remain weak in the latest quarter. In Q1 2026, revenue increased modestly year over year, but the company still posted a sizable net loss and negative operating cash flow. The balance sheet remains strong thanks to a large cash position, but that cushion has been coming down over the last several quarters.

  • Revenue grew year over year in Q1 2026, rising to $27.9 million from $26.8 million in Q4 2025 and $29.9 million in Q1 2025. The recent trend suggests sales are at least holding up better than many investors may have feared.
  • Gross profit improved slightly to $11.8 million in Q1 2026, up from $10.9 million in Q4 2025, indicating the company is still generating healthy gross margin dollars before overhead.
  • Cash and investments still provide a large liquidity buffer. OraSure ended Q1 2026 with $176.96 million in cash and equivalents and another $24.87 million in long-term investments.
  • Debt appears manageable relative to liquidity, with short-term debt of $18.8 million and total liabilities of $65.8 million versus $313.3 million of equity.
  • Share count has drifted lower recently, with weighted average basic shares in Q1 2026 at 69.7 million versus 73.5 million in Q4 2025 and 74.8 million in Q1 2025, which helps EPS over time.
  • The company’s operating model is still not close to break-even. Q1 2026 operating loss was $23.3 million, only slightly worse than the $20.1 million operating loss in Q4 2025.
  • Other income helped soften the loss. Q1 2026 included $1.5 million in other income, but that was not enough to offset the operating deficit.
  • The business continues to burn cash from operations, with Q1 2026 operating cash flow of negative $13.9 million.
  • Capital spending is modest, with Q1 2026 purchases of property and equipment of just $0.9 million, suggesting management is keeping reinvestment restrained.
  • Net loss widened sharply year over year to $22.4 million in Q1 2026 from $16.0 million in Q1 2025 and $19.3 million in Q4 2025.
  • Operating expenses remain too high for current revenue. Q1 2026 operating expenses of $35.1 million were well above gross profit of $11.8 million.
  • Cash is trending lower. Cash and equivalents fell to $176.96 million in Q1 2026 from $216.48 million in Q3 2025 and $247.57 million in Q1 2025.
  • Financing activity is consuming cash, including $5.0 million of common stock repurchases in Q1 2026 and another $1.28 million in other financing outflows.
  • Net cash declined materially in the quarter, with total cash and equivalents dropping by $22.3 million after accounting for operations, investing, financing, and FX effects.

Bottom line: OraSure has enough liquidity to keep operating, but the core story remains the same: revenue is relatively stable, while operating losses and cash burn are still significant. For retail investors, the key question is whether management can keep growing sales and narrow expenses fast enough to move toward sustainable profitability before the cash balance continues to shrink.

07/05/26 12:02 AM ETAI Generated. May Contain Errors.

OraSure Technologies Financials - Frequently Asked Questions

According to the most recent income statement we have on file, OraSure Technologies' financial year ends in December. Their financial year 2025 ended on December 31, 2025.

OraSure Technologies' net income appears to be on a downward trend, with a most recent value of -$68.73 million in 2025, falling from $8.17 million in 2015. The previous period was -$19.50 million in 2024. Find out what analysts predict for OraSure Technologies in the coming months.

OraSure Technologies' total operating income in 2025 was -$71.97 million, based on the following breakdown:
  • Total Gross Profit: $48.20 million
  • Total Operating Expenses: $120.17 million

Over the last 10 years, OraSure Technologies' total revenue changed from $119.72 million in 2015 to $115.02 million in 2025, a change of -3.9%.

OraSure Technologies' total liabilities were at $62.34 million at the end of 2025, a 10.1% decrease from 2024, and a 108.6% increase since 2015.

In the past 10 years, OraSure Technologies' cash and equivalents has ranged from $71.03 million in 2017 to $290.41 million in 2023, and is currently $199.28 million as of their latest financial filing in 2025.

Over the last 10 years, OraSure Technologies' book value per share changed from 2.82 in 2015 to 4.75 in 2025, a change of 68.3%.


Related Companies

Financial statements for NASDAQ:OSUR last updated on 7/2/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Porter flew 3,300 miles to investigate this system
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...
Porter & Company | Sponsoredtc pixel
Better than SpaceX? Grab this ticker instead.
Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...
Brownstone Research | Sponsoredtc pixel
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...
Chaikin Analytics | Sponsoredtc pixel
Elon's new "super startup"
Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...
Banyan Hill Publishing | Sponsoredtc pixel